Many who have schizophrenia don’t respond to antipsychotic drugs. That’s why experts are cheering the US Food and Drug ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

Jamie Alan, PhD, an associate professor of pharmacology and toxicology at Michigan State University, agrees. “Lowering blood sugar would theoretically help dementia, particularly vascular dementia,” ...

Multidisciplinary board members bring expertise in drug discovery, clinical development, computational life science, GPCRs and drug formulationBOSTON, Sept. 30, 2024 (GLOBE NEWSWIRE) -- , Inc., “The ...

BENTON – Calloway County Sheriff’s Office personnel assisted with recent search warrant that resulted in multiple drug ...

Medical doctor and former professor of medicine Paul Marik, found out September 18, that Amazon had banned his book Cancer ...

Government Medical College in Anantnag hosted a conference of the Indian Society for Rational Pharmacotherapeutics, focusing ...

For decades, people with schizophrenia have only had one major form of medication to help quell disturbing symptoms. On ...

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...

Drs. Lisa Baker, Kristina Lemmer and Elena Litvinova are being recognized for their world-renowned contributions to their ...

Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic small- ...

What is the Center for NextGen Therapeutics? The Center for Nextgen Therapeutics (CNGT) primarily focuses on developing ...